Planet Pharmacies LLC

Planet Pharmacies LLC, headquartered in Dubai, UAE, specializes in the distribution of pharmaceutical products and services through over 115 retail pharmacies, focusing on enhancing health and wellness across the region. Founded in 2007 in Dubai, Planet Pharmacies LLC operates in the pharmaceutical industry, providing a wide range of health products. The company was acquired by Gulf Pharmaceutical Industries (Julphar) in June 2021, granting it a 100 percent ownership after initially holding a 40 percent stake since its inception. The founder, Nihal Hakeem, has played a pivotal role in the company's establishment and growth.

Planet Pharmacies LLC specializes in the distribution of pharmaceutical products and services, operating over 115 retail pharmacies across the United Arab Emirates and Oman. The company offers a diverse range of products, including prescription medications, over-the-counter drugs, and various health and wellness items aimed at addressing common health issues faced by consumers. Their services enhance patient health and well-being, catering to both individual consumers and healthcare providers requiring reliable pharmaceutical supplies, with operations encompassing both retail and wholesale distribution. Planet Pharmacies generates revenue through a structured transaction model that includes both retail and wholesale operations.

The company supplies a variety of pharmaceutical products to healthcare providers, pharmacies, and consumers directly. Retail transactions are facilitated through their pharmacies where customers purchase medications and health-related products. Wholesale agreements ensure a consistent supply of their products, contributing significantly to the company's sales figures while supporting both B2B and direct-to-consumer sales channels. Following the acquisition in June 2021, Planet Pharmacies LLC is focused on expanding its distribution and retail presence in the pharmacy healthcare sector across the UAE, Saudi Arabia, and Oman.

The recent funding will support these initiatives, enhancing operational capabilities and market reach. The aim is to establish a stronger foothold in these markets by developing new products tailored to regional demands, improving customer service, and increasing pharmacy locations by the end of 2023.